All tagged Personalised Health
The past decade has seen a Tsunami of data produced within and outside the healthcare apparatus. Modern inquiries into determining healthcare outcomes at an individual level and across populations. Requires significant trans-disciplinary expertise to extract valuable information, and gain actionable knowledge to deliver positive healthcare outcomes.
The global nutrigenomics market size is expected to reach USD 850.86 million by 2025. Registering a CAGR of 16.48%. Obesity is the biggest segment for nutrigenomics and is projected to account for 38% of the total industry by 2025.
Nutrigenomics is the study of molecular relationships between nutritional stimuli and the response of the genes. It opens a window in our understanding of how nutrition influences metabolic pathways and homeostatic control.
The first human genome based on the Sanger technology, a gene sequencing method, occurred in 2001. The Human Genome Project, was a multinational collaboration, that took 13 years to complete, involved hundreds of DNA sequencing machines and cost, approximately between US$0.5-US$1bn.
Across the globe, consortiums, comprised of government, academia, companies from the field of genetics, venture capital and healthcare institutions are collaborating on population-wide genomic projects. Primarily to lay the foundation for precision medicine. Through the derivation of insights obtained from the genomic data of thousands of people across the globe.
There is a growing demand from consumers to gain access to more personalised health information. That provide insights into their predisposition to diseases, guidelines into diet based on nutrigenomics, and their culturally specific needs.